Bruker Appoints Philip Ma to its Board of Directors
BILLERICA, Mass.–(BUSINESS WIRE)– Bruker Corporation (Nasdaq: BRKR) today announced that its Board of Directors has appointed Philip Ma, Ph.D. to serve on its board, effective as of April 1, 2022. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220316005639/en/ Dr. Philip Ma is Chief Executive Officer, President, and Founder of PrognomiQ (Photo: Business... Read more